Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 0 | 1,250 | 0 | 0 | 0 |
| Gross Profit | N/A | 1,250 | N/A | N/A | N/A |
| Operating Expenses | 2,548 | 3,888 | 3,100 | 1,963 | 8,501 |
| Operating Income | -2,548 | -2,638 | -3,100 | -1,963 | -8,501 |
| Interest Expense | 1 | 1 | 1 | 1 | 1 |
| Pre-tax Income | -2,549 | -2,639 | -3,101 | -1,965 | -8,502 |
| Income Tax | N/A | N/A | N/A | 2 | 5 |
| Net Income Continuous | -2,549 | -2,639 | -3,101 | -1,967 | -8,506 |
| Net Income | $-2,549 | $-2,639 | $-3,101 | $-1,967 | $-8,502 |
| EPS Basic Total Ops | -8.11 | -10.21 | -12.61 | -15.32 | -79.28 |
| EPS Basic Continuous Ops | -8.27 | -9.45 | -11.58 | -11.59 | -66.60 |
| EPS Diluted Total Ops | -8.11 | -10.21 | -12.61 | -15.32 | -79.28 |
| EPS Diluted Continuous Ops | -8.27 | -9.45 | -11.58 | -11.59 | -66.60 |
| EBITDA(a) | $-2,467 | $-2,588 | $-3,097 | $-1,958 | $-8,496 |